These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10872202)

  • 1. Podophyllotoxin.
    Canel C; Moraes RM; Dayan FE; Ferreira D
    Phytochemistry; 2000 May; 54(2):115-20. PubMed ID: 10872202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podophyllotoxin and its derivatives: Potential anticancer agents of natural origin in cancer chemotherapy.
    Motyka S; Jafernik K; Ekiert H; Sharifi-Rad J; Calina D; Al-Omari B; Szopa A; Cho WC
    Biomed Pharmacother; 2023 Feb; 158():114145. PubMed ID: 36586242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryltetralin lignans: chemistry, pharmacology and biotransformations.
    Botta B; Delle Monache G; Misiti D; Vitali A; Zappia G
    Curr Med Chem; 2001 Sep; 8(11):1363-81. PubMed ID: 11562272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin.
    Kumar A; Kumar V; Alegria AE; Malhotra SV
    Curr Med Chem; 2011; 18(25):3853-70. PubMed ID: 21824101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Podophyllum peltatum accessions for podophyllotoxin production.
    Moraes RM; Bedir E; Barrett H; Burandt C; Canel C; Khan IA
    Planta Med; 2002 Apr; 68(4):341-4. PubMed ID: 11988859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010).
    Lv M; Xu H
    Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Lignan Content in Extracts from Linum, Callitris and Juniperus Species in Relation to Their In Vitro Antiproliferative Activities.
    Doussot J; Mathieu V; Colas C; Molinié R; Corbin C; Montguillon J; Moreno Y Banuls L; Renouard S; Lamblin F; Dupré P; Maunit B; Kiss R; Hano C; Lainé E
    Planta Med; 2017 Apr; 83(6):574-581. PubMed ID: 27776375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podophyllotoxins: current status and recent developments.
    Damayanthi Y; Lown JW
    Curr Med Chem; 1998 Jun; 5(3):205-52. PubMed ID: 9562603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide phosphate: what, why, where, and how?
    Schacter L
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):1-7. PubMed ID: 8996569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor properties of podophyllotoxin and related compounds.
    Gordaliza M; Castro MA; del Corral JM; Feliciano AS
    Curr Pharm Des; 2000 Dec; 6(18):1811-39. PubMed ID: 11102564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid analysis of lignans from leaves of Podophyllum peltatum L. samples using UPLC-UV-MS.
    Avula B; Wang YH; Moraes RM; Khan IA
    Biomed Chromatogr; 2011 Nov; 25(11):1230-6. PubMed ID: 21374649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic cyclolignans related to podophyllotoxin.
    Gordaliza M; Miguel del Corral JM; Angeles Castro M; García-García PA; San Feliciano A
    Farmaco; 2001 Apr; 56(4):297-304. PubMed ID: 11421258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podophyllum peltatum possesses a beta-glucosidase with high substrate specificity for the aryltetralin lignan podophyllotoxin.
    Dayan FE; Kuhajek JM; Canel C; Watson SB; Moraes RM
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):157-63. PubMed ID: 12637023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podophyllotoxin: a novel potential natural anticancer agent.
    Ardalani H; Avan A; Ghayour-Mobarhan M
    Avicenna J Phytomed; 2017; 7(4):285-294. PubMed ID: 28884079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007.
    Xu H; Lv M; Tian X
    Curr Med Chem; 2009; 16(3):327-49. PubMed ID: 19149581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of lignans in prevention and treatment of cancers].
    Lamblin F; Hano C; Fliniaux O; Mesnard F; Fliniaux MA; Lainé E
    Med Sci (Paris); 2008 May; 24(5):511-9. PubMed ID: 18466729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High yield of podophyllotoxin from leaves of Podophyllum peltatum by in situ conversion of podophyllotoxin 4- O-beta-D-glucopyranoside.
    Canel C; Dayan FE; Ganzera M; Khan IA; Rimando A; Burandt CL; Moraes RM
    Planta Med; 2001 Feb; 67(1):97-9. PubMed ID: 11270736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin.
    Eyberger AL; Dondapati R; Porter JR
    J Nat Prod; 2006 Aug; 69(8):1121-4. PubMed ID: 16933860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis, total synthesis, and pharmacological activities of aryltetralin-type lignan podophyllotoxin and its derivatives.
    Shen S; Tong Y; Luo Y; Huang L; Gao W
    Nat Prod Rep; 2022 Sep; 39(9):1856-1875. PubMed ID: 35913409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents.
    You Y
    Curr Pharm Des; 2005; 11(13):1695-717. PubMed ID: 15892669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.